Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 198

1.

Moving towards a Network of Autonomous UAS Atmospheric Profiling Stations for Observations in the Earth's Lower Atmosphere: The 3D Mesonet Concept.

Chilson PB, Bell TM, Brewster KA, Britto Hupsel de Azevedo G, Carr FH, Carson K, Doyle W, Fiebrich CA, Greene BR, Grimsley JL, Kanneganti ST, Martin J, Moore A, Palmer RD, Pillar-Little EA, Salazar-Cerreno JL, Segales AR, Weber ME, Yeary M, Droegemeier KK.

Sensors (Basel). 2019 Jun 17;19(12). pii: E2720. doi: 10.3390/s19122720. Review.

2.

Adverse events associated with diphenhydramine in children, 2008-2015.

Palmer RB, Reynolds KM, Banner W, Randall Bond G, Kauffman RE, Paul IM, Green JL, Dart RC.

Clin Toxicol (Phila). 2019 May 7:1-8. doi: 10.1080/15563650.2019.1609683. [Epub ahead of print]

PMID:
31062642
3.

Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies.

Hardan AY, Hendren RL, Aman MG, Robb A, Melmed RD, Andersen KA, Luchini R, Rahman R, Ali S, Jia XD, Mallick M, Lateiner JE, Palmer RH, Graham SM.

Autism. 2019 Apr 26:1362361318824103. doi: 10.1177/1362361318824103. [Epub ahead of print]

PMID:
31027422
4.

The Acute Care for Elders Unit Model of Care.

Palmer RM.

Geriatrics (Basel). 2018 Sep 11;3(3). pii: E59. doi: 10.3390/geriatrics3030059.

5.

Analysis of oral bacterial communities: comparison of HOMINGS with a tree-based approach implemented in QIIME.

Palmer RJ, Cotton SL, Kokaras AS, Gardner P, Grisius M, Pelayo E, Warner B, Paster BJ, Alevizos I.

J Oral Microbiol. 2019 Apr 1;11(1):1586413. doi: 10.1080/20002297.2019.1586413. eCollection 2019.

6.

Predictors of the Placebo Response in Irritable Bowel Syndrome With Constipation.

Palmer RH.

Clin Gastroenterol Hepatol. 2019 May;17(6):1215-1216. doi: 10.1016/j.cgh.2018.12.020. Epub 2018 Dec 21. No abstract available.

PMID:
30583047
7.

Evaluation of the quality and value of data sources for postmarket surveillance of the safety of cough and cold medications in children.

Green JL, Reynolds KM, Banner W, Bond GR, Kauffman RE, Palmer RB, Paul IM, Dart RC.

BMC Med Res Methodol. 2018 Dec 22;18(1):175. doi: 10.1186/s12874-018-0626-3.

8.

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.

Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K, Polanco M, Grant R, Griffiths RR.

Front Psychol. 2018 Dec 6;9:2459. doi: 10.3389/fpsyg.2018.02459. eCollection 2018.

9.

Trauma Consults by Geriatricians: Looking Into the Black Box.

Duran SF, Mazzurco L, Palmer RM.

Gerontol Geriatr Med. 2018 Dec 11;4:2333721418817668. doi: 10.1177/2333721418817668. eCollection 2018 Jan-Dec.

10.

A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder.

Barsuglia JP, Polanco M, Palmer R, Malcolm BJ, Kelmendi B, Calvey T.

Prog Brain Res. 2018;242:121-158. doi: 10.1016/bs.pbr.2018.08.002. Epub 2018 Oct 25.

PMID:
30471678
11.

Arthroscopic Treatment of Ankle Instability: Brostrom.

Acevedo JI, Palmer RC, Mangone PG.

Foot Ankle Clin. 2018 Dec;23(4):555-570. doi: 10.1016/j.fcl.2018.07.003. Epub 2018 Sep 25. Review.

PMID:
30414652
12.

The Human Right to Water and Unconventional Energy.

Palmer RC, Short D, Auch WET.

Int J Environ Res Public Health. 2018 Aug 28;15(9). pii: E1858. doi: 10.3390/ijerph15091858. Review.

13.

Bile Acid Deficiency and Constipation.

Palmer RH.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1363-1364. doi: 10.1016/j.cgh.2018.04.018. No abstract available.

PMID:
30033178
14.

Requirements for the collection of electronic PROMS either "in clinic" or "at home" as part of the PROMs, PREMs and Effectiveness Programme (PPEP) in Wales: a feasibility study using a generic PROM tool.

O'Connell S, Palmer R, Withers K, Saha N, Puntoni S, Carolan-Rees G; PROMs, PREMs and Effectiveness Programme.

Pilot Feasibility Stud. 2018 Jul 4;4:90. doi: 10.1186/s40814-018-0282-8. eCollection 2018.

15.

Country, climate change adaptation and colonisation: insights from an Indigenous adaptation planning process, Australia.

Nursey-Bray M, Palmer R.

Heliyon. 2018 Mar 14;4(3):e00565. doi: 10.1016/j.heliyon.2018.e00565. eCollection 2018 Mar.

16.

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.

Patel NR, Cunoosamy DM, Fagerås M, Taib Z, Asimus S, Hegelund-Myrbäck T, Lundin S, Pardali K, Kurian N, Ersdal E, Kristensson C, Korsback K, Palmér R, Brown MN, Greenaway S, Siew L, Clarke GW, Rennard SI, Make BJ, Wise RA, Jansson P.

Int J Chron Obstruct Pulmon Dis. 2018 Mar 27;13:1009-1019. doi: 10.2147/COPD.S150576. eCollection 2018.

17.

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.

White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, Hunt B, Castillo M, Gunawardhana L; CARES Investigators.

N Engl J Med. 2018 Mar 29;378(13):1200-1210. doi: 10.1056/NEJMoa1710895. Epub 2018 Mar 12.

18.

Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure-Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects.

Palmér R, Mäenpää J, Jauhiainen A, Larsson B, Mo J, Russell M, Root J, Prothon S, Chialda L, Forte P, Egelrud T, Stenvall K, Gardiner P.

Clin Pharmacol Ther. 2018 Dec;104(6):1155-1164. doi: 10.1002/cpt.1053. Epub 2018 Apr 16.

19.

The influence of febuxostat on coronary artery endothelial dysfunction in patients with coronary artery disease: A phase 4 randomized, placebo-controlled, double-blind, crossover trial.

Hays AG, Iantorno M, Schär M, Lai S, Czarny M, Breton E, Palmer RN, Whelton A, Weiss RG, Gerstenblith G.

Am Heart J. 2018 Mar;197:85-93. doi: 10.1016/j.ahj.2017.11.006. Epub 2017 Nov 23.

PMID:
29447788
20.

Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.

Gunawardhana L, McLean L, Punzi HA, Hunt B, Palmer RN, Whelton A, Feig DI.

J Am Heart Assoc. 2017 Nov 4;6(11). pii: e006683. doi: 10.1161/JAHA.117.006683.

Supplemental Content

Loading ...
Support Center